Estilo de vida para prevenir el cáncer de mama

Estilo de vida para prevenir el cáncer de mama

El Cáncer de mama (Ca.m) es la neoplasia más frecuente en la población femenina mundial y es un problema de salud en muchos países desarrollados. Colombia no es ajena a esta problemática y presenta tasas de  incidencia y de mortalidad intermedias. En este país se han identificado zonas de alto riesgo, entre las que se encuentran las capitales de los departamentos del Eje Cafetero, el Valle del Cauca, Tolima, Cundinamarca y  Santander. Muchos factores de riesgo se han asociado con esta patología; de éstos el que potencialmente se  puede modificar más fácilmente es el estilo de vida, que depende en gran parte de cada mujer. Si se adoptan estilos de vida saludables se podrían prevenir, disminuir la morbil... Ver más

Guardado en:

Hacia la Promoción de la Salud

0121-7577

2462-8425

Castaño Molina, Eduardo

UNIVERSIDAD DE CALDAS

11

2005-01-01

12

18

Colombia

Colombia

Cáncer de mama

prevención

Estilos de vida

http://purl.org/coar/access_right/c_abf2

info:eu-repo/semantics/openAccess

Hacia la Promoción de la Salud - 2006

id cbf3de1d9f616777411d5eb073c5c24c
record_format ojs
spelling Estilo de vida para prevenir el cáncer de mama
Lieber C., Cytochrome P-450E1: Its Physiological and pathological Role Physiol Rev, 77 (1997) 517-544.
Sontag J. M., Carcinogenicity of substitutedbenzendiamines J Natl Cancer Inst.; 66 (1981) 591-602.
Iwata, F., Zhang, X. Y., Leung, F. W., Aggravation of gastric mucosal lesions in rat stomach by tobacco cigarette smoke. Digest. Dis. Sci., 40 (1995) 1118-1124.
Mirvish, S. S., Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett., 93 (1995) 17-48.
González, C. A., Pera, G., Agudo, A., Palli, D., Krogh, V., Vineis, P., Tumino, T., et al., Smoking and the risk of gastric cancer in the european prospective investigation into cancer and nutrition (EPIC) Int. J. Cancer, 107 (2003) 629-634.
Schoket B., Phillips D., Kostic S., Vincze I., Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients. Carcinogenesis, 19 (1998) 841-846.
Gronbaek M., Becker U., Johansen D. et al. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Annals of Internal Medicine, 133 (2000;) 411-419.
Ardies C. M., Smith T. J., Kim S., Yang C. S., Induction of 4-(methylnitrosamino)-1-(3-pyridil)-butanona (NNK) activation in rat lung microsomes by chronic ethanol consumption and repeated running exercise, Cancer Lett, 103 (1996) 209-218.
Swann P. F., Coe A. M., Mace R., Ethanol and diemthylnitrosamine and diethylnitrosamine metabolism and disposition in rat. Possible relevance to influence of enthanol on human cancer incidence, Carcinogenesis, 5 (1984) 1337-1343.
Takkouche B., Mahyar E., Montes-Martínez A., Personal Use of Hair Dyes and Risk of Cancer A Meta-analysis, JAMA,293 (2005) 2516-2525.
Seitz H. K., Garro A. J., Lieber C. S., Enhanced pulmonary and intestinal activaction of procarcinógenos and mutagens after chronic ethanol consumption in the rat. Eur J Clin Investig, 11 (1981) 33-38.
Fang J. L., Vaca C. E., Detection of DNA adducts of acetaldehyde in peripheral white blood cells of alcohol abusers, Carcinogenesis, 18 (1997) 627-632.
Blot W. J., Invited commentary: more evidence of increased risks of cancer among drinkes. Am J Epidemiol, 150 (1999) 1138-1140.
Rieck G., Fiander A., The effect of lifestyle factors on gynaecological cancer, Best Practice & Research Clinical Obstetrics and Gynaecology, 20 (2006) 227-251.
Rossouw J. E., Anderson G. L., Prentice R. L., LaCroix A. Z., Kooperberg C., Stefanick M. L., Jackson R. D., Beresford S. A., Howard B. V., Johnson K. C., Kotchen J. M., Ockene J., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial, JAMA, 288 (2002) 321-333.
Ross R. K., Paganini-Hill A., Wan P. C., Pike M. C., Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin, J. Natl. Cancer Inst., 92 (2000) 328-332.
La Vecchia C., Estrogen and combined estrogen-progestogen therapy in the menopause and breast cancer. Breast; 13 (2004) 515-518.
Petro-Nustas W., Norton M. E., al-Masarweh I.; Risk factors for breast cancer in Jordanian women, J Nurs Scholarsh, 34 (2002) 19-25.
Evans G. W., Kantrowitz E., Socioeconomic status and health: The Potential Role of Environmental Risk Exposure. Annu. Rev. Public Health, 23 (2002) 303-31.
Jernstrom H., Bendahl P. O., Lidfeldt J. et al. A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women’s health in the lund area (WHILA) study (Sweden). Cancer Causes and Control, 14 (2003) 673-680.
Laden F., Collman G., Iwamoto K., et al. 1,1-Dichloro-2,2-bis(pchlorophenyl) ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five US studies. J Natl Cancer Inst 93 (2001) 768-776.
Text
http://purl.org/coar/access_right/c_abf2
info:eu-repo/semantics/openAccess
http://purl.org/coar/version/c_970fb48d4fbd8a85
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:eu-repo/semantics/article
Biglia N., Defabiani E., Ponzone R., Mariani L., Marenco D., Sismondi P., Management of risk of breast carcinoma in postmenopausal women, Endocr. Relat. Cancer, 11 (2004) 69-83.
Martin F. L., Venitt S., Carmichael P. L., Crofton-Sleigh C., Stone E. M., Cole K. J., et al., DNA damage in breast epithelial cells: detection by the single-cell gel (comet) assay and induction by human mammary lipid extracts, Carcinogenesis, 18 (1997) 2299-2305.
Hulka B. S., Moorman P. G., Breast cancer: hormones and other risk factors, Maturitas, 38 (2001) 103-113.
Modan B., Alfandary E., Chetrit A., Katz L. Increased risk of breast cancer after low-dose irradiation. Lancet; 333 (1989) 629-31.
Yamamoto S., Sobue T., Kobayashi M. et al. Soy, isoflavones, and breast cancer risk in Japan. Journal of the National Cancer Institute; 95 (2003) 906-913.
IARC (ed.) Cruciferous Vegetables, Isothiocyanates and Indoles. Lyon: IARC Press, 2004.
IARC (International agency for research on cancer) Press Release No. 157: Vegetables and fruits do not protect against breast cancer. www.iarc.fr; 2005.
Martin F. L., Cole K. J., Harvey D. P., Weaver G., Williams J. A., Millar B. C., et al., DNA damage in human breast milk cells and its induction by “early” and “late” milk extracts. Carcinogenesis 21 (2000) 799-804.
Scott W. N., Miller W. R., The mutagenic activity of human breast secretions. J. Cancer Res. Clin. Oncol., 116 (1990) 499-502.
Martin, F. L., Carmichael P. L., Crofton-Sleigh C., Venitt S., Phillips D. H., Grover P. L., Genotoxicity of human mammary lipid. Cancer Res., 56 (1996) 5342-5346.
Beral V., Breast cancer and hormone-replacement therapy in the million women study. Lancet; 362 (2003) 419-427.
European Society of Human Reproduction and Embryology. Hormones and breast cancer. Human Reproduction Update; 10 (2004) 281-293.
Publication
https://revistasojs.ucaldas.edu.co/index.php/hacialapromociondelasalud/article/view/1929
11
, Año 2006 : Enero - Diciembre
Artículo de revista
Colombia
Cáncer de mama
Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer, Contraception, 54 (1996) 1S-106S.
application/pdf
Universidad de Caldas
Hacia la Promoción de la Salud
prevención
Estilos de vida
Castaño Molina, Eduardo
Español
https://creativecommons.org/licenses/by-nc-sa/4.0/
Hacia la Promoción de la Salud - 2006
El Cáncer de mama (Ca.m) es la neoplasia más frecuente en la población femenina mundial y es un problema de salud en muchos países desarrollados. Colombia no es ajena a esta problemática y presenta tasas de  incidencia y de mortalidad intermedias. En este país se han identificado zonas de alto riesgo, entre las que se encuentran las capitales de los departamentos del Eje Cafetero, el Valle del Cauca, Tolima, Cundinamarca y  Santander. Muchos factores de riesgo se han asociado con esta patología; de éstos el que potencialmente se  puede modificar más fácilmente es el estilo de vida, que depende en gran parte de cada mujer. Si se adoptan estilos de vida saludables se podrían prevenir, disminuir la morbilidad y mortalidad ocasionada por el Ca.m  en las regiones de alta incidencia.
Mitra A. K., Faruque F. S., Avis A. L., Breast cancer and environmental risks: where is the link? J. Environ. Health 66 (2004) 24-32.
Chacko P., Joseph T., Mathew B. S., Rajan B., Pillai M. R., Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome, Mutation Research 581 (2005) 153-163.
Veronesi U., Boyle P., Goldhirsch A., Orecchia R., Viale G., Breast cancer, Lancet; 365 (2005) 1727-41.
Bernstein L., Epidemiology of endocrine-related risk factors for breast cancer, J. Mammary. Gland. Biol. Neoplasia., 7 (2002) 3-15.
Dumitrescu R. G., Cotarla I., Understanding breast cancer risk -where do we stand in 2005? J. Cell. Mol. Med., 9 (2005) 208-221.
Lambe M., Hsieh C., Trichopoulos D., Ekbom A., Pavia M., Adami H. O., Transient increase in the risk of breast cancer after giving birth, N. Engl. J. Med., 331 (1994) 5-9.
Beral V., Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease, The Lancet, 360 (2002) 187-195.
Breast cancer
Breast cancer is the most frequent neoplasm in the global feminine population and it is a public health problem in developed countries. Colombia is not exempt to this problem presenting intermediate rates of incidence and  mortality. High risk areas have been identified in Colombia, mainly the capitals of the departments of the Coffee Growing Zone, as well as Valle del Cauca, Tolima, Cundinamarca and Santander. Many risk factors have being  associated with this pathology; from these, the factor that can be modified more easily is the lifestyle which  mainly depends of each woman. Adopting a healthy lifestyle could prevent these risk factors and diminish the  mortality caused by breast cancer in the high incidence regions.
Lifestyles
prevention
-
Colombia
-
Journal article
https://revistasojs.ucaldas.edu.co/index.php/hacialapromociondelasalud/article/download/1929/1845
2006-01-01T00:00:00Z
2006-01-01T00:00:00Z
0121-7577
2462-8425
https://revistasojs.ucaldas.edu.co/index.php/hacialapromociondelasalud/article/view/1929
12
18
2005-01-01
institution UNIVERSIDAD DE CALDAS
thumbnail https://nuevo.metarevistas.org/UNIVERSIDADDECALDAS/logo.png
country_str Colombia
collection Hacia la Promoción de la Salud
title Estilo de vida para prevenir el cáncer de mama
spellingShingle Estilo de vida para prevenir el cáncer de mama
Castaño Molina, Eduardo
Colombia
Cáncer de mama
prevención
Estilos de vida
Breast cancer
Lifestyles
prevention
Colombia
title_short Estilo de vida para prevenir el cáncer de mama
title_full Estilo de vida para prevenir el cáncer de mama
title_fullStr Estilo de vida para prevenir el cáncer de mama
title_full_unstemmed Estilo de vida para prevenir el cáncer de mama
title_sort estilo de vida para prevenir el cáncer de mama
title_eng -
description El Cáncer de mama (Ca.m) es la neoplasia más frecuente en la población femenina mundial y es un problema de salud en muchos países desarrollados. Colombia no es ajena a esta problemática y presenta tasas de  incidencia y de mortalidad intermedias. En este país se han identificado zonas de alto riesgo, entre las que se encuentran las capitales de los departamentos del Eje Cafetero, el Valle del Cauca, Tolima, Cundinamarca y  Santander. Muchos factores de riesgo se han asociado con esta patología; de éstos el que potencialmente se  puede modificar más fácilmente es el estilo de vida, que depende en gran parte de cada mujer. Si se adoptan estilos de vida saludables se podrían prevenir, disminuir la morbilidad y mortalidad ocasionada por el Ca.m  en las regiones de alta incidencia.
description_eng Breast cancer is the most frequent neoplasm in the global feminine population and it is a public health problem in developed countries. Colombia is not exempt to this problem presenting intermediate rates of incidence and  mortality. High risk areas have been identified in Colombia, mainly the capitals of the departments of the Coffee Growing Zone, as well as Valle del Cauca, Tolima, Cundinamarca and Santander. Many risk factors have being  associated with this pathology; from these, the factor that can be modified more easily is the lifestyle which  mainly depends of each woman. Adopting a healthy lifestyle could prevent these risk factors and diminish the  mortality caused by breast cancer in the high incidence regions.
author Castaño Molina, Eduardo
author_facet Castaño Molina, Eduardo
topicspa_str_mv Colombia
Cáncer de mama
prevención
Estilos de vida
topic Colombia
Cáncer de mama
prevención
Estilos de vida
Breast cancer
Lifestyles
prevention
Colombia
topic_facet Colombia
Cáncer de mama
prevención
Estilos de vida
Breast cancer
Lifestyles
prevention
Colombia
citationvolume 11
citationedition , Año 2006 : Enero - Diciembre
publisher Universidad de Caldas
ispartofjournal Hacia la Promoción de la Salud
source https://revistasojs.ucaldas.edu.co/index.php/hacialapromociondelasalud/article/view/1929
language Español
format Article
rights http://purl.org/coar/access_right/c_abf2
info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/4.0/
Hacia la Promoción de la Salud - 2006
references Lieber C., Cytochrome P-450E1: Its Physiological and pathological Role Physiol Rev, 77 (1997) 517-544.
Sontag J. M., Carcinogenicity of substitutedbenzendiamines J Natl Cancer Inst.; 66 (1981) 591-602.
Iwata, F., Zhang, X. Y., Leung, F. W., Aggravation of gastric mucosal lesions in rat stomach by tobacco cigarette smoke. Digest. Dis. Sci., 40 (1995) 1118-1124.
Mirvish, S. S., Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett., 93 (1995) 17-48.
González, C. A., Pera, G., Agudo, A., Palli, D., Krogh, V., Vineis, P., Tumino, T., et al., Smoking and the risk of gastric cancer in the european prospective investigation into cancer and nutrition (EPIC) Int. J. Cancer, 107 (2003) 629-634.
Schoket B., Phillips D., Kostic S., Vincze I., Smoking-associated bulky DNA adducts in bronchial tissue related to CYP1A1 MspI and GSTM1 genotypes in lung patients. Carcinogenesis, 19 (1998) 841-846.
Gronbaek M., Becker U., Johansen D. et al. Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer. Annals of Internal Medicine, 133 (2000;) 411-419.
Ardies C. M., Smith T. J., Kim S., Yang C. S., Induction of 4-(methylnitrosamino)-1-(3-pyridil)-butanona (NNK) activation in rat lung microsomes by chronic ethanol consumption and repeated running exercise, Cancer Lett, 103 (1996) 209-218.
Swann P. F., Coe A. M., Mace R., Ethanol and diemthylnitrosamine and diethylnitrosamine metabolism and disposition in rat. Possible relevance to influence of enthanol on human cancer incidence, Carcinogenesis, 5 (1984) 1337-1343.
Takkouche B., Mahyar E., Montes-Martínez A., Personal Use of Hair Dyes and Risk of Cancer A Meta-analysis, JAMA,293 (2005) 2516-2525.
Seitz H. K., Garro A. J., Lieber C. S., Enhanced pulmonary and intestinal activaction of procarcinógenos and mutagens after chronic ethanol consumption in the rat. Eur J Clin Investig, 11 (1981) 33-38.
Fang J. L., Vaca C. E., Detection of DNA adducts of acetaldehyde in peripheral white blood cells of alcohol abusers, Carcinogenesis, 18 (1997) 627-632.
Blot W. J., Invited commentary: more evidence of increased risks of cancer among drinkes. Am J Epidemiol, 150 (1999) 1138-1140.
Rieck G., Fiander A., The effect of lifestyle factors on gynaecological cancer, Best Practice & Research Clinical Obstetrics and Gynaecology, 20 (2006) 227-251.
Rossouw J. E., Anderson G. L., Prentice R. L., LaCroix A. Z., Kooperberg C., Stefanick M. L., Jackson R. D., Beresford S. A., Howard B. V., Johnson K. C., Kotchen J. M., Ockene J., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial, JAMA, 288 (2002) 321-333.
Ross R. K., Paganini-Hill A., Wan P. C., Pike M. C., Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin, J. Natl. Cancer Inst., 92 (2000) 328-332.
La Vecchia C., Estrogen and combined estrogen-progestogen therapy in the menopause and breast cancer. Breast; 13 (2004) 515-518.
Petro-Nustas W., Norton M. E., al-Masarweh I.; Risk factors for breast cancer in Jordanian women, J Nurs Scholarsh, 34 (2002) 19-25.
Evans G. W., Kantrowitz E., Socioeconomic status and health: The Potential Role of Environmental Risk Exposure. Annu. Rev. Public Health, 23 (2002) 303-31.
Jernstrom H., Bendahl P. O., Lidfeldt J. et al. A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women’s health in the lund area (WHILA) study (Sweden). Cancer Causes and Control, 14 (2003) 673-680.
Laden F., Collman G., Iwamoto K., et al. 1,1-Dichloro-2,2-bis(pchlorophenyl) ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five US studies. J Natl Cancer Inst 93 (2001) 768-776.
Biglia N., Defabiani E., Ponzone R., Mariani L., Marenco D., Sismondi P., Management of risk of breast carcinoma in postmenopausal women, Endocr. Relat. Cancer, 11 (2004) 69-83.
Martin F. L., Venitt S., Carmichael P. L., Crofton-Sleigh C., Stone E. M., Cole K. J., et al., DNA damage in breast epithelial cells: detection by the single-cell gel (comet) assay and induction by human mammary lipid extracts, Carcinogenesis, 18 (1997) 2299-2305.
Hulka B. S., Moorman P. G., Breast cancer: hormones and other risk factors, Maturitas, 38 (2001) 103-113.
Modan B., Alfandary E., Chetrit A., Katz L. Increased risk of breast cancer after low-dose irradiation. Lancet; 333 (1989) 629-31.
Yamamoto S., Sobue T., Kobayashi M. et al. Soy, isoflavones, and breast cancer risk in Japan. Journal of the National Cancer Institute; 95 (2003) 906-913.
IARC (ed.) Cruciferous Vegetables, Isothiocyanates and Indoles. Lyon: IARC Press, 2004.
IARC (International agency for research on cancer) Press Release No. 157: Vegetables and fruits do not protect against breast cancer. www.iarc.fr; 2005.
Martin F. L., Cole K. J., Harvey D. P., Weaver G., Williams J. A., Millar B. C., et al., DNA damage in human breast milk cells and its induction by “early” and “late” milk extracts. Carcinogenesis 21 (2000) 799-804.
Scott W. N., Miller W. R., The mutagenic activity of human breast secretions. J. Cancer Res. Clin. Oncol., 116 (1990) 499-502.
Martin, F. L., Carmichael P. L., Crofton-Sleigh C., Venitt S., Phillips D. H., Grover P. L., Genotoxicity of human mammary lipid. Cancer Res., 56 (1996) 5342-5346.
Beral V., Breast cancer and hormone-replacement therapy in the million women study. Lancet; 362 (2003) 419-427.
European Society of Human Reproduction and Embryology. Hormones and breast cancer. Human Reproduction Update; 10 (2004) 281-293.
Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer, Contraception, 54 (1996) 1S-106S.
Mitra A. K., Faruque F. S., Avis A. L., Breast cancer and environmental risks: where is the link? J. Environ. Health 66 (2004) 24-32.
Chacko P., Joseph T., Mathew B. S., Rajan B., Pillai M. R., Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome, Mutation Research 581 (2005) 153-163.
Veronesi U., Boyle P., Goldhirsch A., Orecchia R., Viale G., Breast cancer, Lancet; 365 (2005) 1727-41.
Bernstein L., Epidemiology of endocrine-related risk factors for breast cancer, J. Mammary. Gland. Biol. Neoplasia., 7 (2002) 3-15.
Dumitrescu R. G., Cotarla I., Understanding breast cancer risk -where do we stand in 2005? J. Cell. Mol. Med., 9 (2005) 208-221.
Lambe M., Hsieh C., Trichopoulos D., Ekbom A., Pavia M., Adami H. O., Transient increase in the risk of breast cancer after giving birth, N. Engl. J. Med., 331 (1994) 5-9.
Beral V., Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease, The Lancet, 360 (2002) 187-195.
type_driver info:eu-repo/semantics/article
type_coar http://purl.org/coar/resource_type/c_6501
type_version info:eu-repo/semantics/publishedVersion
type_coarversion http://purl.org/coar/version/c_970fb48d4fbd8a85
type_content Text
publishDate 2005-01-01
date_accessioned 2006-01-01T00:00:00Z
date_available 2006-01-01T00:00:00Z
url https://revistasojs.ucaldas.edu.co/index.php/hacialapromociondelasalud/article/view/1929
url_doi https://revistasojs.ucaldas.edu.co/index.php/hacialapromociondelasalud/article/view/1929
issn 0121-7577
eissn 2462-8425
citationstartpage 12
citationendpage 18
url2_str_mv https://revistasojs.ucaldas.edu.co/index.php/hacialapromociondelasalud/article/download/1929/1845
_version_ 1797376235179868160

Código QR

Estadísticas y Métricas Alternativas

Títulos similares